The much anticipated launch of MiyoSmart lenses with D.I.M.S. Technology in Australia and New Zealand has been announced.
Hoya Lens Australia will launch the innovative lens, which features award winning technology, on 1 October 2020.
The trial concluded that children wearing defocus lenses had 60% less myopia progression* compared with those wearing single-vision lenses
MiyoSmart with D.I.M.S. Technology is a spectacle lens for myopia control in children, developed in collaboration with Hoya Corporation’s research collaborator, The Hong Kong Polytechnic University. Following years of academic studies, product design and clinical research, Hoya Corporation and The Hong Kong Polytechnic University developed a revolutionary spectacle lens, based on a Defocus Incorporated Multiple Segments Technology or ‘D.I.M.S. Technology’, which won the Grand Prize, Grand Award and Gold Medal at the 46th International Exhibition of Inventions of Geneva in April 2018.
Wearing defocus spectacle lenses daily significantly slows myopia progression and axial elongation in myopic children aged eight to 13, according to a two-year double-blind randomised clinical trial conducted in Hong Kong.
The trial concluded that children wearing defocus lenses had 60% less myopia progression* compared with those wearing single-vision lenses. These findings provide strong evidence that defocus lenses are effective in reducing myopia progression.
MiyoSmart lenses are an effective non-invasive method to manage myopia which can be fitted to a myopic child at any age, like regular single vision lenses. MiyoSmart’s efficacy is based on patent protected D.I.M.S segments creating a myopic defocus effect.
The lenses feature a low-maintenance multi-coat that is water repellent, easy to wipe and durable, with UV protection making it suitable for children.
With the focus on educating both eye care professionals and parents on the importance of treating myopia and the various options that are currently available, MiyoSmart will be a welcome product to help combat myopia as a safe, easy and effective, non-invasive option with proven results.
“This is the myopia management option that the Australian and New Zealand market has been waiting for. We are proud to provide such an effective treatment with award winning technology” said Craig Chick, Managing Director of Hoya Lens Australia. He said MiyoSmart “highlights Hoya’s leadership in the optical industry”.
Eye care professionals who plan to dispense MiyoSmart lenses will be required to meet accreditation criteria. For more information, please contact your Hoya Sales Consultant or call 1800 500 971 (Australia) or 0800 744 692 (New Zealand).
*Myopia progression (SER) by 59% and axial elongation (AL) decreased by 60% compared with those wearing single vision lenses.